Skeletal Muscle Aging and Responsiveness in Aged People With MS

Part of paid clinical trials in Oklahoma City, Oklahoma.

Sponsor
Oklahoma Medical Research Foundation
Study ID
NCT07500727
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
60 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Exercise trial consisting of both cardiovascular and strength training — OTHER
    All participants will receive 12 weeks of combined ET and RT. All exercise is supervised with a certified trainer. All study staff are CPR trained. Progression of volume and intensity will occur during the ramp-up week and into the first week of training. The ramp-up period increases the number of sets, repetitions, and intensity to limit excessive muscle damage, soreness, and fatigue. Full volume training will be achieved by the end of week one and progression thereafter will be based on intensity. Participants will complete 3x/wk ET and 3x/week RT. Both ET and RT will be progressed on an individual level via monitoring of each session with pragmatic increases in cycling wattage, treadmill speed/grade, and weight lifted as needed. At the completion of training there will be a testing week that repeats the battery of testing completed during the wash-in period to determine responder status by the a priori designated MCIDs for CRF and fMQ.

Study Details

The purposes of this study are to: 1) compare baseline muscle and cardiovascular health in older individuals (\>60 years old) diagnosed with MS to age-matched people without MS, 2) determine muscle and whole body changes to an exercise training program, 3) determine if the muscle in a more affected leg in individuals diagnosed with MS is different from the muscle of a less affected leg, and 4) if or how individuals diagnosed with MS adapt differently than age-matched people without MS to exercise training. Participation in this study will average 1.5 hours per visit, 3 visits per week, for approximately 4 months.

Key Dates

Start date
Mar 6, 2026
Status verified
Mar 2026
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
10 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER

Arms

  • Experimental: People with MS
    People with MS, 60 or older

Primary Outcome Measure

fMQ [ Time Frame: Week -3 and Week -2 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Oklahoma Medical Research FoundationOklahoma CityOklahoma73104
Lena Fuentes
4052717745

Find similar trials in Oklahoma City, OK

By condition

Related Studies